NCT06218121 Update on the Detection of Frailty in Older Adults
| NCT ID | NCT06218121 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad Europea de Madrid |
| Condition | Strength |
| Study Type | OBSERVATIONAL |
| Enrollment | 500 participants |
| Start Date | 2024-04-20 |
| Primary Completion | 2025-04-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500 participants in total. It began in 2024-04-20 with a primary completion date of 2025-04-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The main objective is to update the diagnostic assessment of frailty by correlating several variables with the ultrasound image of the frail elderly patient. Secondarily, the investigators intend to collect and analyze data on functional capacity and quality of life variables on the evolution of musculoskeletal symptoms, as well as on pain and psychological variables. Similarly, it is intended to make a record of different profiles and subtypes of frail older adult patients to be stored in Machine Learning in order to establish therapeutic intervention plans that allow both the evaluation and treatment of patients.
Eligibility Criteria
Inclusion Criteria: A diagnosis of signs and symptoms of frailty by a geriatric physician in the research group will be used as the primary inclusion criterion. Frailty will be assessed and diagnosed using the frailty phenotype and the Clinical Frailty Scale. Exclusion Criteria: * Acute myocardial infarction in the last 3 months and/or unstable angina pectoris * Uncontrolled arrhythmia, recent thromboembolism and terminal illness. * Patients undergoing MMII unloading or MMSS/MMII fractures in the last three months. * Patients with a functional gait index of 1 (Inability to walk) * Severe pain (7/10 VAS) * Previous neuromuscular pathology presenting with weakness * Medication that does not allow the patient's actual muscle reaction to be assessed * Severe cognitive impairment that would prevent collaboration and understanding of the tests to be performed. * Cardiovascularly unstable patients and uncontrolled arterial hypertension.
Contact & Investigator
Eleuterio A. A. Sánchez Romero, PhD
PRINCIPAL INVESTIGATOR
European University of Madrid
Frequently Asked Questions
Who can join the NCT06218121 clinical trial?
This trial is open to participants of all sexes, aged 62 Years or older, studying Strength. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06218121 currently recruiting?
Yes, NCT06218121 is actively recruiting participants. Contact the research team at eleuterio.sanchez@universidadeuropea.es for enrollment information.
Where is the NCT06218121 trial being conducted?
This trial is being conducted at Madrid, Spain.
Who is sponsoring the NCT06218121 clinical trial?
NCT06218121 is sponsored by Universidad Europea de Madrid. The principal investigator is Eleuterio A. A. Sánchez Romero, PhD at European University of Madrid. The trial plans to enroll 500 participants.